Orelabrutinib

Generic Name
Orelabrutinib
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C26H25N3O3
CAS Number
1655504-04-3
Unique Ingredient Identifier
WJA5UO9E10
Background

Orelabrutinib is under investigation in clinical trial NCT04305197 (A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)).

Indication

⑴既往至少接受过一种治疗的成人套细胞淋巴瘤(MCL)患者。

⑵既往至少接受过一种治疗的成人慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)患者。

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath